Products

Versius Plus
CMR Surgical
Surgical AI
Versius Plus is an FDA-cleared, next-generation robotic surgical platform by CMR Surgical, designed for versatility and adaptability with a digital ecosystem providing data-driven insights for optimized surgical performance and efficiency. It is currently cleared for cholecystectomy and has a 510(k) submission filed for benign gynecologic indications.

See all 1 product →

About CMR Surgical

CMR Surgical is a global medical technology company dedicated to transforming surgical care through its Versius® Surgical Robotic System. For physicians, Versius is a next-generation, modular, and portable robotic platform designed to enhance the accessibility and efficacy of minimal access surgery (MAS). The system mimics the human arm, offering surgeons natural arm motion, familiar techniques, and the dexterity of small, fully-wristed instruments, which allows for precise surgical maneuvers and flexible port placement tailored to the patient and procedure.

Versius is utilized across a broad spectrum of soft-tissue specialties, including gynaecology, general surgery, thoracic surgery, urology, and colorectal surgery, in hospitals across Europe, the Middle East, Asia, Australia, and Latin America, with recent FDA clearance for cholecystectomy in the U.S.. The system’s compact and modular design allows for easy movement between operating rooms, eliminating the need for dedicated robotic suites and enabling seamless integration into existing hospital workflows. CMR Surgical also emphasizes a digitally driven ecosystem, with applications like Versius Connect and Versius Team providing surgeons and hospital teams with near-real-time procedural logbooks and dashboards to track usage, case volume, and system efficiency, supporting continuous learning and optimization of robotic programs.

The company is also focusing on the future of ‘Intelligent Surgery’ by integrating AI and computer vision for intraoperative guidance, aiming to further enhance surgical precision and outcomes. With over 45,000 procedures completed worldwide, CMR Surgical is committed to making robotic-assisted surgery more widely available and affordable, challenging traditional models with its flexible and cost-effective approach.

Focus Areas

Surgical robotics minimal access surgery robotic-assisted surgery general surgery gynaecology urology colorectal surgery thoracic surgery digital surgery AI in healthcare surgical data platforms

Business Intelligence

Key InvestorsAlly Bridge Group, SoftBank Vision Fund, PFM Health Sciences, Cambridge Innovation Capital, Trinity Capital, Escala Capital, LGT, RPMI Railpen, Tencent, Watrium, GE Healthcare, ABB Technology Ventures
Partnerships20 NHS hospital partnerships (UK), hospital and ambulatory surgery center partnerships (US), NVIDIA (Physical AI healthcare robotics initiative)
TechnologyVersius® Surgical System (and Versius Plus), a modular, portable surgical robotic system with fully-wristed instruments, 3D HD vision, open surgeon console, integrated fluorescence visualization (vLimeLite), and a digital ecosystem including Versius Connect (surgeon app) and Versius Team (hospital app) for data insights. Involved in NVIDIA's Physical AI healthcare robotics initiative and contributing to the Open-H dataset.
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Surgical Robotics & Minimal Access Surgery (MAS)
CMR Surgical specializes in robotic-assisted minimal access surgery (MAS) with its Versius Plus Surgical System. Versius Plus is a next-generation, portable, and modular surgical robot designed to make MAS more accessible and affordable globally. The system features independent robotic arms that can be positioned around the patient, allowing for flexible port placement and seamless integration into existing operating room (OR) setups without requiring dedicated infrastructure. It is designed to mimic the human arm, providing surgeons with the dexterity and accuracy of small, fully-wristed instruments and 3D HD vision. Versius Plus is indicated for adult patients eligible for soft tissue minimal access surgery, with initial FDA 510(k) clearance for cholecystectomy procedures in the U.S., and submissions filed for other indications like benign gynecologic procedures. The system has been used in over 45,000 surgical procedures globally across multiple specialties, making it the second most utilized soft-tissue robotic surgical platform worldwide.
Digital Surgery & AI in Healthcare
The Versius system is powered by a comprehensive digital ecosystem that integrates data, simulation, and AI to enhance surgical care. This ecosystem includes Versius Connect, a dedicated surgeon app providing a near-real-time logbook of procedures with in-depth case statistics, synchronized videos, and instrument usage timelines. Versius Team is a live dashboard for surgical teams and hospitals, tracking usage, case volume, and system efficiency to optimize robotics programs. CMR Surgical is actively collaborating with NVIDIA on its Physical AI healthcare robotics initiative, contributing a significant amount of surgical data to the Open-H dataset to train the next generation of intelligent surgical systems. The goal is to leverage AI to deliver real-time insights and recommendations at the point of care, ultimately improving patient outcomes and democratizing minimally invasive surgery.
Surgical Data Platforms
Versius captures extensive robotic telemetry data, procedural case videos, and clinical context information through the CMR Registry. This data is consolidated into 'Versius Clinical Insights,' providing surgeons and hospitals with actionable information to understand the full clinical story of each procedure. These insights support continuous learning and development, allow for analysis of aggregated surgical performance (e.g., complications, blood loss, length of stay), and enable benchmarking against anonymized data from other Versius hospitals.
Specialties Supported
The Versius Surgical System supports a broad range of soft-tissue procedures across multiple specialties. These include general surgery (e.g., cholecystectomy, hernia repair, appendicitis), gynaecology (e.g., hysterectomy, fibroid surgery), urology (e.g., prostatectomies), and thoracic surgery. CMR Surgical is also conducting clinical trials and pursuing expanded indications, including in pediatric surgery.
Physician Tip

For physicians, CMR Surgical's Versius Plus offers several key advantages. Its compact, modular design allows for flexible port placement and easy integration into diverse OR setups, enhancing surgical versatility. The biomimetic, fully-wristed instruments, combined with 3D HD vision and natural instrument control, aim to improve surgical precision and dexterity, potentially reducing surgeon fatigue during long procedures. The open surgeon console facilitates clear communication with the surgical team, fostering a collaborative environment. Furthermore, the digital ecosystem, including Versius Connect and Versius Clinical Insights, provides surgeons with real-time data, procedural logbooks, and performance metrics to support continuous learning, skill development, and informed decision-making, ultimately aiming to improve patient outcomes. CMR also emphasizes comprehensive, metrics-based training pathways to ensure standardization in surgical skills.

The Versius system is built with a digitally-driven ecosystem at its core. It integrates with dedicated apps like Versius Connect for surgeons and Versius Team for surgical teams, providing real-time data, procedural insights, and performance dashboards. CMR Surgical is also actively collaborating with NVIDIA, leveraging their Physical AI platform (including Open-H dataset and IGX Thor) to accelerate the development of next-generation intelligent surgical robotic systems, aiming for AI-powered real-time surgical support and enhanced capabilities.

Products by CMR Surgical

1 product in the directory

Versius Plus
CMR Surgical
Surgical AI
Versius Plus is an FDA-cleared, next-generation robotic surgical platform by CMR Surgical, designed for versatility and adaptability with a digital ecosystem providing data-driven insights for optimized surgical performance and efficiency. It is currently cleared for cholecystectomy and has a 510(k) submission filed for benign gynecologic indications.

What the Web Says

CMR Surgical is a company that has developed the Versius surgical robotic system, which is used for minimal access surgery across various specialties. The product, Versius, generally receives positive feedback from surgeons and hospitals for its modular design, portability, and effectiveness in a range of procedures, leading to improved patient outcomes and quicker recovery times. However, employee reviews indicate a mixed sentiment regarding the company culture and management, with concerns about internal politics, heavy workloads, and poor management decisions, despite many employees being passionate about the product and their colleagues.

Overall: Mixed

Strengths

  • Versius surgical system is safe and effective in minimal access surgery.
  • Modular and portable design of Versius allows for flexibility and adaptability in operating rooms.
  • Surgeons report improved outcomes and quicker recovery times for patients using Versius.
  • Versius offers increased precision, accuracy, and dexterity for surgeons due to its V-wrist technology.
  • High level of collaboration and a sense of achievement among employees regarding the product.
  • Many employees find colleagues to be fantastic and supportive.

Limitations

  • Poor management and internal politics are frequently cited issues by employees.
  • Concerns about job security and advancement opportunities.
  • Heavy workloads and accompanying stress reported by employees.
  • Upper management has been accused of ignoring employee input and scaling up too fast.
  • Lack of planning, strategy, and recognition from management.
  • Some procedures with Versius required conversion to conventional laparoscopic or open surgery.

Based on reviews from: Indeed.com, SimplyHired, PMC (PubMed Central), General Surgery News, G2, Oxford Academic, Reddit, News Medical Life Sciences, Facebook, Capterra, ZipRecruiter

Last updated: 2026-08-28

Videos

News, demos, and interviews about CMR Surgical.

Loading videos...

Videos load interactively. If none appear, search YouTube for CMR Surgical →

View all on YouTube

Press & Coverage

Medical Product Outsourcing
CMR Surgical Reveals Surgical Robot Milestone, Prepares to Enter U.S. Market
CMR Surgical announced that its Versius surgical robotic system has treated over 45,000 patients globally, a significant milestone as the company prepares to expand into the U.S. market following FDA clearance of its next-gen Versius Plus system.
2026-03
CMR Surgical
CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system
CMR Surgical's second-generation surgical robotic platform, Versius Plus, received 510(k) clearance from the FDA for cholecystectomy procedures, paving the way for its commercial launch in the U.S. in 2026.
2025-12
CMR Surgical
CMR Surgical Closes Over $200M to Accelerate Growth
CMR Surgical successfully closed a financing round of over $200 million through equity and debt, with funds aimed at accelerating the global commercial expansion of the Versius Surgical Robotic System, particularly its launch in the United States.
2025-04
Business Weekly
US FDA clears new robotic surgery technology from CMR Surgical
Cambridge-based CMR Surgical received FDA clearance for its second-generation Versius Plus surgical robotic platform for cholecystectomy procedures, opening up the North American market for the technology.
2026-01
GlobeNewswire
CMR Surgical Announces 45,000 Patients Treated Globally as Robotic-Assisted Surgery Company Makes Its U.S. Debut
CMR Surgical announced that its Versius Surgical Robotic System has treated over 45,000 patients worldwide, a significant milestone coinciding with the company's expansion into the U.S. market.
2026-03
CMR Surgical
CMR Surgical Submits 510(k) Application to US FDA to Expand Versius Plus into Gynecology
CMR Surgical submitted a 510(k) premarket notification to the U.S. FDA for its Versius Plus Surgical Robotic System, seeking clearance for benign gynecology procedures.
2026-04
SPINEMarketGroup
CMR Surgical Considers Potential $4 Billion Sale Amid Global Expansion of Versius Robot
CMR Surgical is reportedly exploring a potential sale valued at around $4 billion, a move that comes as the company expands globally and strengthens its position in the robotic-assisted surgery market.
2025-06
ResearchGate
CMR Versius Robotic Platform in Urinary Tract Tumors: A Tertiary Center Experience
A prospective observational study evaluated the safety and efficacy of the Versius robotic surgical platform in managing urological malignancies, concluding it appears to be a safe and effective option with acceptable perioperative outcomes.
2026-06

Frequently Asked Questions

The CMR Surgical Versius system is indicated for a broad range of minimal access surgeries, including general surgery, gynaecology, urology, colorectal, and thoracic surgery. Its key features include a modular and portable design, fully wristed instruments that mimic human dexterity, 3D HD vision, and an open surgeon console designed to reduce fatigue and facilitate communication.
CMR Surgical's Versius Plus system received FDA 510(k) clearance for cholecystectomy in the United States in December 2025, with a 510(k) submission also filed for benign gynecologic indications. The company also holds UL certification in India and has successfully passed surveillance audits for ISO 9001, ISO 14001, and ISO 45001, demonstrating adherence to international quality, environmental, and occupational health and safety standards.
CMR Surgical offers flexible pricing models for its Versius system, including capital purchases, Managed Service Agreements, and pay-per-use plans. This approach is designed to lower the barrier to adoption for hospitals and surgical centers, making robotic-assisted surgery more accessible and affordable globally.
CMR Surgical provides comprehensive and ongoing training for surgical teams, which includes a metrics-based program, digital and eLearning platforms, and a VR simulator called Versius Trainer. This training pathway is accredited by the Royal College of Surgeons of England and is designed to ensure effective use and continuous learning.
The Versius system is powered by a digital ecosystem that includes Versius Clinical Insights, Versius Connect for surgeons, and Versius Team for surgical staff. These platforms gather robotic telemetry data, procedural videos, and clinical context to provide actionable insights, support continuous learning, and help optimize robotic programs and decision-making.
CMR Surgical, founded in 2014, has demonstrated strong growth and stability, having raised over $1.2 billion in funding, including a $200 million round in April 2025 to support its U.S. launch and global expansion. The company's Versius system is the second most utilized robotic surgical platform globally, with over 45,000 procedures performed across more than 30 countries, indicating significant market adoption and confidence.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.